Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | 3-oxo-5-alpha-steroid 4-dehydrogenase | 0.0101 | 1 | 0.5 |
Echinococcus granulosus | synaptic glycoprotein sc2 | 0.0101 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.2711 | 0.2711 |
Loa Loa (eye worm) | hypothetical protein | 0.0101 | 1 | 1 |
Echinococcus multilocularis | 3 oxo 5 alpha steroid 4 dehydrogenase, C terminal | 0.0101 | 1 | 1 |
Toxoplasma gondii | 3-oxo-5-alpha-steroid 4-dehydrogenase | 0.0101 | 1 | 0.5 |
Plasmodium vivax | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0101 | 1 | 0.5 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0101 | 1 | 0.5 |
Onchocerca volvulus | 0.0101 | 1 | 0.5 | |
Entamoeba histolytica | trans-2,3-enoyl-CoA reductase, putative | 0.0101 | 1 | 1 |
Schistosoma mansoni | synaptic glycoprotein sc2 related | 0.0101 | 1 | 1 |
Schistosoma mansoni | synaptic glycoprotein sc2 related | 0.0101 | 1 | 1 |
Entamoeba histolytica | steroid 5-alpha reductase, putative | 0.0101 | 1 | 1 |
Leishmania major | 3-oxo-5-alpha-steroid 4-dehydrogenase-like protein | 0.0101 | 1 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.5047 | 0.5047 |
Brugia malayi | 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0.0101 | 1 | 1 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0101 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.5047 | 0.5047 |
Brugia malayi | hypothetical protein | 0.0043 | 0.2992 | 0.2992 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.2992 | 0.2992 |
Plasmodium falciparum | polyprenol reductase, putative | 0.0101 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.2992 | 0.2992 |
Mycobacterium ulcerans | hypothetical protein | 0.0101 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.2711 | 0.2711 |
Entamoeba histolytica | 3-oxo-5-alpha-steroid 4-dehydrogenase domain-containing protein | 0.0101 | 1 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.5047 | 0.5047 |
Giardia lamblia | Synaptic glycoprotein SC2 | 0.0101 | 1 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.2711 | 0.2711 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0101 | 1 | 0.5 |
Toxoplasma gondii | 3-oxo-5-alpha-steroid 4-dehydrogenase | 0.0101 | 1 | 0.5 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0101 | 1 | 0.5 |
Echinococcus granulosus | 3 oxo 5 alpha steroid 4 dehydrogenase C terminal | 0.0101 | 1 | 1 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0101 | 1 | 0.5 |
Trypanosoma brucei | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0101 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0101 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0101 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0101 | 1 | 0.5 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.0101 | 1 | 0.5 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.0101 | 1 | 0.5 |
Trypanosoma brucei | 3-oxo-5-alpha-steroid 4-dehydrogenase-like, putative | 0.0101 | 1 | 0.5 |
Echinococcus multilocularis | synaptic glycoprotein sc2 | 0.0101 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0101 | 1 | 1 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0101 | 1 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.5047 | 0.5047 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.2992 | 0.2992 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0101 | 1 | 0.5 |
Plasmodium vivax | polyprenol reductase, putative | 0.0101 | 1 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.2992 | 0.2992 |
Loa Loa (eye worm) | hypothetical protein | 0.0101 | 1 | 1 |
Plasmodium falciparum | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0101 | 1 | 0.5 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.0101 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 5.6234 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.8048 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.081 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.